Skip to main content
Premium Trial:

Request an Annual Quote

Appeals Court Affirms Enzo Defeat in Patent Dispute

NEW YORK, April 4 - The US Court of Appeals for the Federal Circuit affirmed a summary judgment that an Enzo Biochem patent directed at certain nucleic-acid probes is invalid because it lacks a written description of its claimed invention.

The three-judge panel affirmed the ruling by a two-to-one vote on Tuesday. Enzo, which stressed that the decision will not have any financial impact, said it was "disappointed" and will seek a rehearing before the full court of appeals. 
Enzo's suit named as defendants Becton-Dickinson, BioMerieux, Chugai Pharmaceutical, Chugai Pharma USA, and Gen-Probe.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.